Lange Louis G

Lange Louis G is listed in filings as Director at NewAmsterdam Pharma Company N.V.. This profile follows SEC Form 4 activity through Mar 12, 2026, including sale activity. Recent filings connect the profile to NewAmsterdam Pharma Company N.V. (NAMS). The current snapshot covers public activity from Jan 8, 2025 to Mar 12, 2026. Reported amounts are shown as $840.1K to $829.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.